-
CME/CE
Revised Antiretroviral Therapy Guidelines Issued for Teens and Adults With HIV-1
Revisions of the use of antiretroviral agents for adolescents and adults with HIV-1 infection update the January 2008 guidelines for the use of antiretroviral agents in this population.
Medscape Medical News, November 2008
-
CME
FDA Safety Changes: Nasacort AQ, Reyataz, Zemuron
The FDA has approved revisions to the safety labeling for triamcinolone acetonide nasal spray, atazanavir sulfate capsules, and rocuronium bromide intravenous injection.
Medscape Medical News, November 2008
-
Significant Reduction in Breast Cancer Recurrence and Mortality With Psychologic Intervention
In stage 2 breast cancer patients, a program of psychologic intervention significantly reduced recurrence and mortality risk.
Medscape Medical News, November 2008
-
Counseling May Reduce Clinician Burnout and Stress
A short-term counseling intervention was effective in reducing burnout and stress in a cohort of Norwegian clinicians.
Medscape Medical News, November 2008
-
Ad5 Immune Complexes May Improve HIV Replication
Activation of a dendritic cell T-cell axis by adenovirus type 5 (Ad5) immune complex appears to trigger the process that led to the premature termination of the STEP Ad5 HIV vaccine trial in 2007, European researchers report in an a November 3rd on-line publication in the Journal of Experimental Medicine.
Reuters Health Information, November 2008
-
ACAAI 2008: Skin Test May Be Good Negative Predictor for Anesthetic Allergy
Of the patients who tested negative for local anesthetic allergy, 97% also tested negative by subcutaneous challenge.
Medscape Medical News, November 2008
-
ACAAI 2008: Increased Leptin Levels Linked to Asthma
Patients with moderately persistent asthma had higher leptin levels, while those with intermittent asthma or mild persistent asthma had lower leptin levels.
Medscape Medical News, November 2008
-
Omalizumab Seen Safe, Effective in Children 6 to 11 Years
In children aged 6 to 11 years with inadequately controlled allergic asthma, adding the anti-IgE monoclonal antibody omalizumab (Xolair; Novartis) to optimized treatment leads to a clinically significant reduction in asthma attacks and is well tolerated.
Reuters Health Information, November 2008
-
ACAAI 2008: Mometasone Furoate Nasal Spray Quickly Relieves Allergic Rhinitis Congestion
A newer testing method has shown that mometasone furoate nasal spray provides relief 6 hours after therapy.
Medscape Medical News, November 2008
-
CME
FDA Approvals: Toviaz, Prezista, Astepro
The FDA has approved fesoterodine fumarate extended-release tablets (Toviaz), an expanded indication for darunavir tablets (Prezista), and a new formulation for azelastine HCl nasal spray (Astepro).
Medscape Medical News, November 2008
-
Combined Glycoconjugate Vaccine Can Be Used to Boost Protection in Toddlers
Administration of the conjugate Hib-MenC-TT vaccine (Haemophilus influenza type b and Neisseriae meningitidis serogroup C and tetanus toxoid) as a booster dose at 12 to 15 months of age results in robust protection against Hib and MenC regardless of which type of Hib/MenC vaccines were administered in infancy, according to findings published in the November issue of the Archives of Disease in Childhood.
Reuters Health Information, November 2008
-
ACAAI 2008: Intranasal Steroid Outperforms Antihistamine in Relieving Nighttime Allergy Symptoms
A direct comparison of fluticasone furoate nasal spray and oral fexofenadine showed that fluticasone better relieves nighttime symptoms of seasonal allergic rhinitis.
Medscape Medical News, November 2008
-
Step Study Published: HIV Vaccine Does Not Protect Against HIV-1 Infection
Two studies showed that the latest HIV vaccine from Merck did not protect against HIV-1 infection or reduce early plasma HIV-1 levels.
Medscape Medical News, November 2008
-
ACAAI 2008: Gastroesophageal Reflux Disease Treatment Improves Asthma in Children
After 2 years of GERD treatment, the children showed a significant improvement in lung function, as measured by spirometry, and a reduction in the number of asthma exacerbations.
Medscape Medical News, November 2008
-
ACAAI 2008: Ecallantide Effective for Hereditary Angioedema
In a phase 3 trial, ecallantide, the recombinant peptide plasma kallikrein inhibitor DX-88, reduces the severity of acute hereditary angioedema attacks.
Medscape Medical News, November 2008
-
ACAAI 2008: Immunotherapy Reduces New Allergies in Young Children With Allergic Rhinitis
A retrospective analysis showed that subcutaneous immunotherapy reduced the number of new sensitizations in children younger than 6 years with allergic rhinitis.
Medscape Medical News, November 2008
-
Physicians Urged to Educate Patients on HFA Albuterol Inhalers
The American College of Allergy, Asthma and Immunology (ACAAI) is ramping up efforts to get physicians and the medical community to educate their respiratory disease patients about the upcoming discontinuation of albuterol inhalers using chlorofluorocarbon (CFC) propellants.
Reuters Health Information, November 2008
-
Inadequately Controlled Asthma Common in Primary Care
A significant number of asthma patients visiting their primary care physician for a non-respiratory-related reason have inadequately controlled asthma, according to results of a study presented at the annual meeting of the American College of Allergy, Asthma and Immunology underway in Seattle.
Reuters Health Information, November 2008
-
CME/CE
Prolonged Breast-Feeding May Improve Subsequent Lung Function
In a prospective birth cohort study, infants who were breast-fed for at least 4 months had improved lung function at age 10 years vs those who were not breast-fed.
Medscape Medical News, November 2008
-
AHA 2008: Flu Shot Linked to Reduced Risk of VTE
The link between influenza vaccination and reduced pulmonary embolism or deep vein thrombosis was particularly marked in younger subjects, researchers say.
Heartwire, November 2008
